0001104659-06-054693 Sample Contracts

PONIARD PHARMACEUTICALS, INC. CHANGE OF CONTROL AGREEMENT (VP)

Change of Control Agreement • August 14th, 2006 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Change of Control Agreement
• Filed
  August 14th, 2006
• Company
  Poniard Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This Change of Control Agreement (VP) (this “Agreement”), dated as of July 24, 2006, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 13, the “Company”), and Alan B. Glassberg, M.D. (the “Executive”).

PONIARD PHARMACEUTICALS, INC. KEY EXECUTIVE SEVERANCE AGREEMENT (VP)

Key Executive Severance Agreement • August 14th, 2006 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Key Executive Severance Agreement
• Filed
  August 14th, 2006
• Company
  Poniard Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This Key Executive Severance Agreement (VP) (this “Agreement”), dated as of July 24, 2006, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 10, the “Company”), and Alan B. Glassberg, M.D. (the “Executive”).

PONIARD PHARMACEUTICALS, INC. KEY EMPLOYEE SEVERANCE AGREEMENT

Key Employee Severance Agreement • August 14th, 2006 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances

• Contract Type
  Key Employee Severance Agreement
• Filed
  August 14th, 2006
• Company
  Poniard Pharmaceuticals, Inc.
• Industry
  In vitro & in vivo diagnostic substances

This Key Employee Severance Agreement (this “Agreement”), dated as of July 11, 2006, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 10, the “Company”), and Mike Jackson (the “Employee”).